The multifunctional neuropeptide Cocaine and Amphetamine Regulated Transcript (CART) is secreted from hypothalamus, pituitary, adrenal gland and pancreas. It also can be found in circulatory system. This feature suggests a general role for CART in different cells. In the present study, we demonstrate that CART protects mitochondrial DNA (mtDNA), cellular proteins and lipids against the oxidative action of hydrogen peroxide, a widely used oxidant. Using cis-parinaric acid as a sensitive reporting probe for peroxidation in membranes, and a lipid-soluble azo initiator of peroxyl radicals, 2,2′-Azobis(2,4-dimethylvaleronitrile) we found that CART is an antioxidant. Furthermore, we found that CART localized to mitochondria in cultured cells and mouse brain neuronal cells. More importantly, pretreatment with CART by systemic injection protects against a mouse oxidative stress model, which mimics the main features of Parkinson's disease. Given the unique molecular structure and biological features of CART, we conclude that CART is an antioxidant peptide (or antioxidant hormone). We further propose that it may have strong therapeutic properties for human diseases in which oxidative stress is strongly involved such as Parkinson's disease.
References
[1]
Reichlin S (1993) Neuroendocrine-immune interactions. N Engl J Med 329(17): 1246–1253.
[2]
Ojeda SR, Lomniczi A, Mastronardi C, Heger S, Roth C, et al. (2006) Minireview: The neuroendocrine regulation of puberty: Is the time ripe for a systems biology approach? Endocrinology 147(3): 1166–1174.
[3]
McEwen BS (2008) Central effects of stress hormones in health and disease: Understanding the protective and damaging effects of stress and stress mediators. Eur J Pharmacol 583(2–3): 174–185.
[4]
Snyder SH (2009) Neurotransmitters, receptors, and second messengers galore in 40 years. J Neurosci 29(41): 12717–12721.
[5]
Douglass J, McKinzie AA, Couceyro P (1995) PCR differential display identifies a rat brain mRNA that is transcriptionally regulated by cocaine and amphetamine. J Neurosci 15(3 Pt 2): 2471–2481.
[6]
Kristensen P, Judge ME, Thim L, Ribel U, Christjansen KN, et al. (1998) Hypothalamic CART is a new anorectic peptide regulated by leptin. Nature 393(6680): 72–76.
[7]
Rogge G, Jones D, Hubert GW, Lin Y, Kuhar MJ (2008) CART peptides: Regulators of body weight, reward and other functions. Nat Rev Neurosci 9(10): 747–758.
[8]
del Giudice EM, Santoro N, Cirillo G, D'Urso L, Di Toro R, et al. (2001) Mutational screening of the CART gene in obese children: Identifying a mutation (Leu34Phe) associated with reduced resting energy expenditure and cosegregating with obesity phenotype in a large family. Diabetes 50(9): 2157–2160.
[9]
Hunter RG, Philpot K, Vicentic A, Dominguez G, Hubert GW, et al. (2004) CART in feeding and obesity. Trends Endocrinol Metab 15(9): 454–459.
[10]
Schultz K, Wiehager S, Nilsson K, Nielsen JE, Lindquist SG, et al. (2009) Reduced CSF CART in dementia with lewy bodies. Neurosci Lett 453(2): 104–106.
[11]
Bene R, Antic S, Budisic M, Lisak M, Trkanjec Z, et al. (2009) Parkinson's disease. Acta Clin Croat 48(3): 377–380.
[12]
Couceyro PR, Koylu EO, Kuhar MJ (1997) Further studies on the anatomical distribution of CART by in situ hybridization. J Chem Neuroanat 12(4): 229–241.
[13]
Kuhar MJ, Adams LD, Hunter RG, Vechia SD, Smith Y (2000) CART peptides. Regul Pept 89(1–3): 1–6.
[14]
Mao P (2011) Potential antidepressant role of neurotransmitter CART: Implications for mental disorders. Depress Res Treat 2011: 762139.
[15]
Dallvechia-Adams S, Kuhar MJ, Smith Y (2002) Cocaine- and amphetamine-regulated transcript peptide projections in the ventral midbrain: Colocalization with gamma-aminobutyric acid, melanin-concentrating hormone, dynorphin, and synaptic interactions with dopamine neurons. J Comp Neurol 448(4): 360–372.
[16]
Jaworski JN, Vicentic A, Hunter RG, Kimmel HL, Kuhar MJ (2003) CART peptides are modulators of mesolimbic dopamine and psychostimulants. Life Sci 73(6): 741–747.
[17]
Philpot K, Smith Y (2006) CART peptide and the mesolimbic dopamine system. Peptides 27(8): 1987–1992.
[18]
Hubert GW, Jones DC, Moffett MC, Rogge G, Kuhar MJ (2008) CART peptides as modulators of dopamine and psychostimulants and interactions with the mesolimbic dopaminergic system. Biochem Pharmacol 75(1): 57–62.
[19]
Vicentic A, Dominguez G, Hunter RG, Philpot K, Wilson M, et al. (2004) Cocaine- and amphetamine-regulated transcript peptide levels in blood exhibit a diurnal rhythm: Regulation by glucocorticoids. Endocrinology 145(9): 4119–4124.
[20]
Hunter RG, Bellani R, Bloss E, Costa A, Romeo RD, et al. (2007) Regulation of CART mRNA by stress and corticosteroids in the hippocampus and amygdala. Brain Res 1152: 234–240.
[21]
Vicentic A, Lakatos A, Jones D (2006) The CART receptors: Background and recent advances. Peptides 27(8): 1934–1937.
[22]
Mao P, Ardeshiri A, Jacks R, Yang S, Hurn PD, et al. (2007) Mitochondrial mechanism of neuroprotection by CART. Eur J Neurosci 26(3): 624–632.
[23]
Kim MS, Muratore C, Snelling L, Mandelbaum DE, McEachern R, et al. (2009) Ischemic stroke and rhabdomyolysis in a 15-year-old girl with paraganglioma due to an SDHB exon 6 (Q214X) mutation. J Pediatr Endocrinol Metab 22(6): 565–571.
[24]
Richter C, Park JW, Ames BN (1988) Normal oxidative damage to mitochondrial and nuclear DNA is extensive. Proc Natl Acad Sci U S A 85(17): 6465–6467.
[25]
Yakes FM, Van Houten B (1997) Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proc Natl Acad Sci U S A 94(2): 514–519.
[26]
Wilson GL, Patton NJ, LeDoux SP (1997) Mitochondrial DNA in beta-cells is a sensitive target for damage by nitric oxide. Diabetes 46(8): 1291–1295.
[27]
Mao P, Reddy PH (2011) Aging and amyloid beta-induced oxidative DNA damage and mitochondrial dysfunction in alzheimer's disease: Implications for early intervention and therapeutics. Biochim Biophys Acta 1812(11): 1359–70.
[28]
Simonian NA, Coyle JT (1996) Oxidative stress in neurodegenerative diseases. Annu Rev Pharmacol Toxicol 36: 83–106.
[29]
Jenner P (2007) Oxidative stress and parkinson's disease. Handb Clin Neurol 83: 507–520.
[30]
Mao P, Reddy PH (2010) Is multiple sclerosis a mitochondrial disease? Biochim Biophys Acta 1802(1): 66–79.
[31]
Del Gaizo V, Payne RM (2003) A novel TAT-mitochondrial signal sequence fusion protein is processed, stays in mitochondria, and crosses the placenta. Mol Ther 7(6): 720–730.
[32]
Tsuchiya M, Kagan VE, Freisleben HJ, Manabe M, Packer L (1994) Antioxidant activity of alpha-tocopherol, beta-carotene, and ubiquinol in membranes: Cis-parinaric acid-incorporated liposomes. Methods Enzymol 234: 371–383.
[33]
Kelso GF, Porteous CM, Coulter CV, Hughes G, Porteous WK, et al. (2001) Selective targeting of a redox-active ubiquinone to mitochondria within cells: Antioxidant and antiapoptotic properties. J Biol Chem 276(7): 4588–4596.
[34]
Lin MT, Beal MF (2006) Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443(7113): 787–795.
[35]
Zhou C, Huang Y, Przedborski S (2008) Oxidative stress in parkinson's disease: A mechanism of pathogenic and therapeutic significance. Ann N Y Acad Sci 1147: 93–104.
[36]
Jackson-Lewis V, Przedborski S (2007) Protocol for the MPTP mouse model of parkinson's disease. Nat Protoc 2(1): 141–151.
[37]
Robinson S, Freeman P, Moore C, Touchon JC, Krentz L, et al. (2003) Acute and subchronic MPTP administration differentially affects striatal glutamate synaptic function. Exp Neurol 180(1): 74–87.
[38]
Holmer HK, Keyghobadi M, Moore C, Meshul CK (2005) L-dopa-induced reversal in striatal glutamate following partial depletion of nigrostriatal dopamine with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyri？dine. Neuroscience 136(1): 333–341.
[39]
Goldberg NR, Haack AK, Meshul CK (2011) Enriched environment promotes similar neuronal and behavioral recovery in a young and aged mouse model of parkinson's disease. Neuroscience 172: 443–452.
[40]
Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, et al. (2007) Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39(1): 44–84.
[41]
Reddy PH (2008) Mitochondrial medicine for aging and neurodegenerative diseases. Neuromolecular Med 10(4): 291–315.
[42]
Manczak M, Mao P, Calkins MJ, Cornea A, Reddy AP, et al. (2010) Mitochondria-targeted antioxidants protect against amyloid-beta toxicity in Alzheimer's disease neurons. J Alzheimers Dis Suppl 2: S609–31.
[43]
Pohanka M, Pejchal J, Snopkova S, Havlickova K, Karasova JZ, et al. (2011) Ascorbic acid: an old player with a broad impact on body physiology including oxidative stress suppression and immunomodulation. A review. Mini Rev Med Chem. (in press).
[44]
Reiter R, Tang L, Garcia JJ, Mu？oz-Hoyos A (1997) Pharmacological actions of melatonin in oxygen radical pathophysiology. Life Sci 60(25): 2255–71.
[45]
Hardeland R (2005) Antioxidative protection by melatonin: multiplicity of mechanisms from radical detoxification to radical avoidance. Endocrine 27(2): 119–30.
[46]
Paddenberg R, Ishaq B, Goldenberg A, Faulhammer P, Rose F, et al. (2003) Essential role of complex II of the respiratory chain in hypoxia-induced ROS generation in the pulmonary vasculature. Am J Physiol Lung Cell Mol Physiol 284(5): L710–9.
[47]
Wu B, Hu S, Yang M, Pan H, Zhu S (2006) CART peptide promotes the survival of hippocampal neurons by upregulating brain-derived neurotrophic factor. Biochem Biophys Res Commun 347(3): 656–661.
[48]
Xu Y, Zhang W, Klaus J, Young J, Koerner I, et al. (2006) Role of cocaine- and amphetamine-regulated transcript in estradiol-mediated neuroprotection. Proc Natl Acad Sci U S A 103(39): 14489–14494.
[49]
Ekblad E (2006) CART in the enteric nervous system. Peptides 27(8): 2024–2030.
[50]
Halliwell B, Gutteridge JM (1995) The definition and measurement of antioxidants in biological systems. Free Radic Biol Med 18(1): 125–126.
[51]
Ludvigsen S, Thim L, Blom AM, Wulff BS (2001) Solution structure of the satiety factor, CART, reveals new functionality of a well-known fold. Biochemistry 40(31): 9082–9088.
[52]
Dickinson DA, Forman HJ (2002) Glutathione in defense and signaling: Lessons from a small thiol. Ann N Y Acad Sci 973: 488–504.
[53]
Mao P, Jacks R (2007) Transcriptional activity by cocaine-amphetamine-regulated transcript. Mol Psychiatry 12(3): 223–224.
[54]
Kong WM, Stanley S, Gardiner J, Abbott C, Murphy K, et al. (2003) A role for arcuate cocaine and amphetamine-regulated transcript in hyperphagia, thermogenesis, and cold adaptation. FASEB J 17(12): 1688–1690.
[55]
Meshul CK, McGinty JF (2000) Kappa opioid receptor immunoreactivity in the nucleus accumbens and caudate-putamen is primarily associated with synaptic vesicles in axons. Neuroscience 96(1): 91–9.
[56]
Schang AY, Fisher BE, Sashkin NR, Moore C, Dirling LB, et al. (2010) Correlates and Analysis of Motor Function in Humans and Animal Models of Parkinson's Disease. pp. 55–90.
[57]
Darvesh AS, Carroll RT, Geldenhuys WJ, Gudelsky GA, Klein J, et al. (2011) In vivo brain microdialysis: advances in neuropsychopharmacology and drug discovery. Expert Opin Drug Discov 6(2): 109–127.
[58]
Asnicar MA, Smith DP, Yang DD, Heiman ML, Fox N, Chen YF, et al. (2001) Absence of cocaine- and amphetamine-regulated transcript results in obesity in mice fed a high caloric diet. Endocrinology 142(10): 4394–400.
[59]
Wierup N, Richards WG, Bannon AW, Kuhar MJ, Ahrén B, et al. (2005) CART knock out mice have impaired insulin secretion and glucose intolerance, altered beta cell morphology and increased body weight. Regul Pept 129(1–3): 203–11.
[60]
Bartell SM, Isales CM, Baile CA, Kuhar MJ, Hamrick MW (2008) CART deficiency increases body weight but does not alter bone strength. J Musculoskelet Neuronal Interact 8(2): 146–53.
[61]
Hunter RG, Kuhar MJ (2003) CART peptides as targets for CNS drug development. Curr Drug Targets CNS Neurol Disord 2(3): 201–205.
[62]
Dallvechia-Adams S, Smith Y, Kuhar MJ (2001) CART peptide-immunoreactive projection from the nucleus accumbens targets substantia nigra pars reticulata neurons in the rat. J Comp Neurol 434(1): 29–39.
[63]
Brischoux F, Griffond B, Fellmann D, Risold PY (2002) Early and transient ontogenetic expression of the cocaine- and amphetamine-regulated transcript peptide in the rat mesencephalon: Correlation with tyrosine hydroxylase expression. J Neurobiol 52(3): 221–229.
[64]
Kastin AJ, Akerstrom V (1999) Entry of CART into brain is rapid but not inhibited by excess CART or leptin. Am J Physiol 277(5 Pt 1): E901–4.
[65]
Bjorkqvist M, Leavitt BR, Nielsen JE, Landwehrmeyer B, Ecker D, et al. (2007) Cocaine- and amphetamine-regulated transcript is increased in huntington disease. Mov Disord 22(13): 1952–1954.
[66]
Bech P, Winstanley V, Murphy KG, Sam AH, Meeran K, et al. (2008) Elevated cocaine- and amphetamine-regulated transcript immunoreactivity in the circulation of patients with neuroendocrine malignancy. J Clin Endocrinol Metab 93(4): 1246–1253.
[67]
McEwen BS (2007) Physiology and neurobiology of stress and adaptation: Central role of the brain. Physiol Rev 87(3): 873–904.
[68]
Mao P, Tao YX, Fukaya M, Tao F, Li D, et al. (2008) Cloning and characterization of E-dlg, a novel splice variant of mouse homologue of the drosophila discs large tumor suppressor binds preferentially to SAP102. IUBMB Life 60(10): 684–692.
[69]
Shull S, Heintz NH, Periasamy M, Manohar M, Janssen YM, et al. (1991) Differential regulation of antioxidant enzymes in response to oxidants. J Biol Chem 266(36): 24398–24403.
[70]
Calkins MJ, Reddy PH (2011) Amyloid beta impairs mitochondrial anterograde transport and degenerates synapses in alzheimer's disease neurons. Biochim Biophys Acta 1812(4): 507–513.
[71]
Przedborski S, Tieu K, Perier C, Vila M (2004) MPTP as a mitochondrial neurotoxic model of parkinson's disease. J Bioenerg Biomembr 36(4): 375–379.
[72]
Kamens HM, Phillips TJ, Holstein SE, Crabbe JC (2005) Characterization of the parallel rod floor apparatus to test motor incoordination in mice. Genes Brain Behav 4(4): 253–266.
[73]
Baquet ZC, Williams D, Brody J, Smeyne RJ (2009) A comparison of model-based (2D) and design-based (3D) stereological methods for estimating cell number in the substantia nigra pars compacta (SNpc) of the C57BL/6J mouse. Neuroscience 161(4): 1082–1090.
[74]
Benes FM, Lange N (2001) Two-dimensional versus three-dimensional cell counting: A practical perspective. Trends Neurosci 24(1): 11–17.
